World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
17050
World Ranking
2334
National Ranking
92

Renato Mantegazza publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Renato Mantegazza sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 408 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Renato Mantegazza D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Renato Mantegazza sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Renato Mantegazza is affiliated with the Istituto Neurologico Carlo Besta in Italy. Their research primarily focuses on the field of Medicine, with a significant body of work in Neurology as a major subfield. Additional research interests include Molecular Biology, Genetics, Infectious Diseases, and Oncology.

The scientist's main topics of investigation encompass Myasthenia Gravis and Thymoma, Peripheral Neuropathies and Disorders, Parkinson's Disease and Spinal Disorders, Neurogenetic and Muscular Disorders Research, Cancer Treatment and Pharmacology, Antifungal resistance and susceptibility, and Multiple Sclerosis Research Studies.

Renato Mantegazza has contributed publications to several journals and venues. The most frequent among these include:

  • Neurology
  • Neuromuscular Disorders
  • Zenodo (CERN European Organization for Nuclear Research)
  • Journal of the Neurological Sciences
  • Journal of Neurology

Frequent collaborators in research efforts are:

  • Tuan Vu
  • James F. Howard
  • Kimiaki Utsugisawa
  • Vera Bril
  • Lorenzo Maggi

Renato Mantegazza's recent publications include:

  • Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial, 2021, The Lancet Neurology
  • Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study, 2023, The Lancet Neurology
  • Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study, 2023, The Lancet Neurology
  • Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis, 2022, NEJM Evidence
  • Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3, 2020, Journal of Neurology Neurosurgery & Psychiatry

Best Publications

  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    James F Howard;Kimiaki Utsugisawa;Michael Benatar;Hiroyuki Murai

  • Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis

    Ezio Gerdoni;Barbara Gallo;Simona Casazza;Silvia Musio

  • A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis

    P. Zisimopoulou;P. Evangelakou;J. Tzartos;K. Lazaridis

  • Cytokines and chemokines are both expressed by human myoblasts: Possible relevance for the immune pathogenesis of muscle inflammation

    Marco De Rossi;Pia Bernasconi;Fulvio Baggi;Renè de Waal Malefyt

  • Importance of Shank3 Protein in Regulating Metabotropic Glutamate Receptor 5 (mGluR5) Expression and Signaling at Synapses

    Chiara Verpelli;Elena Dvoretskova;Cinzia Vicidomini;Francesca Rossi

  • GluR3 antibodies: Prevalence in focal epilepsy but no specificity for Rasmussen’s encephalitis

    Heinz Wiendl;C. G. Bien;P. Bernasconi;B. Fleckenstein

  • Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures.

    Renato Mantegazza;Pia Bernasconi;Fulvio Baggi;Roberto Spreafico

  • Experience with immunomodulatory treatments in Rasmussen’s encephalitis

    Tiziana Granata;L. Fusco;G. Gobbi;E. Freri

  • Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection.

    R Mantegazza;F Andreetta;P Bernasconi;F Baggi

  • Immunomodulation of TGF-beta1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: Implications for antifibrotic therapy

    Francesca Andreetta;Pia Bernasconi;Fulvio Baggi;Paolo Ferro

  • Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus

    Paola Cavalcante;Barbara Serafini;Barbara Rosicarelli;Lorenzo Maggi

  • Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study

    Paolo Confalonieri;Laura Oliva;Francesca Andreetta;Rossella Lorenzoni

  • A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy

    R. Mantegazza;E. Beghi;E. Beghi;D. Pareyson;C. Antozzi

  • Long-term selective IgG immunoadsorption improves Rasmussen's encephalitis

    Carlo Antozzi;T. Granata;N. Aurisano;G. Zardini

  • Increased Expression of β-Chemokines in Muscle of Patients with Inflammatory Myopathies

    Paolo Confalonieri;Pia Bernasconi;Paola Megna;Silvia Galbiati

  • Modulation of MHC class II antigen expression in human myoblasts after treatment with IFN‐γ

    R. Mantegazza;S. M. Hughes;D. Mitchell;M. Travis

  • Etiology of myasthenia gravis: Innate immunity signature in pathological thymus

    Paola Cavalcante;Perrine Cufi;Renato Mantegazza;Sonia Berrih-Aknin

  • LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients.

    John S. Tzartos;Paraskevi Zisimopoulou;Michael Rentzos;Nikos Karandreas

  • Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies

    C. Cappelletti;F. Baggi;F. Zolezzi;D. Biancolini

  • Thymoma-associated myasthenia gravis: Outcome, clinical and pathological correlations in 197 patients on a 20-year experience

    Lorenzo Maggi;Francesca Andreetta;Carlo Antozzi;Fulvio Baggi

  • Breakdown of Tolerance to a Self-Peptide of Acetylcholine Receptor α-Subunit Induces Experimental Myasthenia Gravis in Rats

    Fulvio Baggi;Andrea Annoni;Federica Ubiali;Monica Milani

Frequent Co-Authors

Marina Mora
Marina Mora Istituto Neurologico Carlo Besta
Matilde Leonardi
Matilde Leonardi Istituto Neurologico Carlo Besta
Socrates J. Tzartos
Socrates J. Tzartos Institut Pasteur
Roberto Spreafico
Roberto Spreafico Istituto Neurologico Carlo Besta
Renato Longhi
Renato Longhi National Academies of Sciences, Engineering, and Medicine
Tiziana Granata
Tiziana Granata Istituto Neurologico Carlo Besta
Sonia Berrih-Aknin
Sonia Berrih-Aknin Université Paris Cité
Ettore Beghi
Ettore Beghi Mario Negri Institute for Pharmacological Research
Lawrence Steinman
Lawrence Steinman Stanford University
Giuseppe Lauria
Giuseppe Lauria University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can open up diverse career opportunities in healthcare and research. Many professionals begin with foundational nursing programs, and for beginners, there are excellent online nursing programs for non nurses that provide a solid entry point into patient care and biological sciences.

If you already have experience or a degree in another field, accelerated pathways like the easiest accelerated nursing programs offer a streamlined route to becoming a registered nurse. These programs are designed to balance rigorous training with manageable admission criteria, helping you move quickly toward your goals.

For those seeking quicker certifications, the fastest and easiest lpn programs provide practical nursing training in a shorter time frame. These can be valuable stepping stones for gaining hands-on experience while continuing education in immunology or related disciplines.

Advanced practice nurses aiming to specialize may benefit from easy nurse practitioner programs to get into. These programs often focus on specific populations or clinical areas, allowing you to combine clinical expertise with immunological knowledge for impactful healthcare roles.

Best Scientists Citing Renato Mantegazza

Trending Scientists

Recently Published Articles